Literature DB >> 159185

Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors.

A Coutinho, E L Larsson, K O Grönvik, J Andersson.   

Abstract

Growth factors contained in Con A(concanavalin A)-conditioned media (CM) maintain exponential growth in T cell blasts derived from mitogen stimulation of spleen cells with Con A, phytohemagglutinin, lentil lectin and pokeweed mitogen (PWM), as well as from mixed lymphocyte reactions to H-2D or I-C-encoded determinants and from non-H-2 Mls locus-controlled reactions. Such growth factors are strictly T cell blast-specific, inasmuch as they do not stimulate resting, small T or B lymphocytes nor B cell blasts generated by lipopolysaccharide or lipoprotein activation. The responsiveness of T cell blasts to CM appears to be the result of the availability on the cell surface of an acceptor site for growth factors which is not expressed in resting cells, because T cell blasts, but not small spleen cells, absorb out the growth-promoting activity contained in CM. Furthermore, lectins such as Con A and PWM interfere with the blast surface membrane in such a way that they inhibit the response to growth factors. Finally, there is no detectable allotypic or isotypic restriction in the activity of Con A-CM on a variety of target T cell blasts.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159185     DOI: 10.1002/eji.1830090803

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Cloning of human thymic subcapsular cortex epithelial cells with T-lymphocyte binding sites and hemopoietic growth factor activity.

Authors:  S Mizutani; S M Watt; D Robertson; S Hussein; L E Healy; A J Furley; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 2.  Development of glucose-responsive 'smart' insulin systems.

Authors:  Nischay K Rege; Nelson F B Phillips; Michael A Weiss
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-08       Impact factor: 3.243

3.  The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor.

Authors:  D S Milstone; C W Parker
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

4.  Monitoring of interleukin-2 receptor (IL-2R) expression in vivo and studies on an IL-2R-directed immunosuppressive therapy of active and adoptive adjuvant-induced arthritis in rats.

Authors:  K G Stünkel; P Theisen; A Mouzaki; T Diamantstein; H D Schlumberger
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

Review 5.  T cell receptors of autoimmune mice: functional and molecular analysis of novel T cell subsets in C3H-gld/gld mice.

Authors:  K Yui; Y Hashimoto; M I Greene
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

6.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.

Authors:  S Gillis; R Kozak; M Durante; M E Weksler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A.

Authors:  D Armerding
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity.

Authors:  J Bertoglio; D Gerlier; J P Gerard
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

9.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

Authors:  T R Malek; R J Robb; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor.

Authors:  T Leanderson; E Lundgren; E Ruuth; H Borg; H Persson; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.